These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
966 related articles for article (PubMed ID: 18275911)
1. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Del Amo EM; Urtti A Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911 [TBL] [Abstract][Full Text] [Related]
2. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Myles ME; Neumann DM; Hill JM Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884 [TBL] [Abstract][Full Text] [Related]
3. Advances in ocular drug delivery. Rawas-Qalaji M; Williams CA Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004 [TBL] [Abstract][Full Text] [Related]
4. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268 [TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the posterior segment of the eye. Fischer N; Narayanan R; Loewenstein A; Kuppermann BD Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325 [TBL] [Abstract][Full Text] [Related]
7. Microdialysis assessment of drug delivery systems for vitreoretinal targets. Duvvuri S; Rittenhouse KD; Mitra AK Adv Drug Deliv Rev; 2005 Dec; 57(14):2080-91. PubMed ID: 16271800 [TBL] [Abstract][Full Text] [Related]
8. Drug delivery systems for the eye. Kearns VR; Williams RL Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285 [TBL] [Abstract][Full Text] [Related]
9. A new method for posterior sub-Tenon's drug administration. Nesterov AP; Basinsky SN; Isaev A Ophthalmic Surg; 1993 Jan; 24(1):59-61. PubMed ID: 8446337 [TBL] [Abstract][Full Text] [Related]
10. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504 [TBL] [Abstract][Full Text] [Related]
11. Topical and systemic drug delivery to the posterior segments. Hughes PM; Olejnik O; Chang-Lin JE; Wilson CG Adv Drug Deliv Rev; 2005 Dec; 57(14):2010-32. PubMed ID: 16289435 [TBL] [Abstract][Full Text] [Related]
12. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases. Durgun ME; Güngör S; Özsoy Y J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723 [TBL] [Abstract][Full Text] [Related]
14. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Jiao J Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195 [TBL] [Abstract][Full Text] [Related]
15. Nanotechnology in ocular drug delivery. Sahoo SK; Dilnawaz F; Krishnakumar S Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912 [TBL] [Abstract][Full Text] [Related]
16. Drug delivery to the posterior segment of the eye. Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306 [TBL] [Abstract][Full Text] [Related]
17. [Drug delivery to target the posterior segment of the eye]. Behar-Cohen F Med Sci (Paris); 2004; 20(6-7):701-6. PubMed ID: 15329823 [TBL] [Abstract][Full Text] [Related]
18. Nanomaterials for ocular drug delivery. Liu S; Jones L; Gu FX Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445 [TBL] [Abstract][Full Text] [Related]